Position in SANA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,977,836
-$227,004 QoQ
Shares Held
1,139,782
-21.9% QoQ
Ownership
0.381%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. SANA ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,977,836 | 1,139,782 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,204,840 | 1,460,015 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,230,130 | 1,285,045 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $3,111,589 | 876,505 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $4,039,836 | 1,479,795 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,387,114 | 825,664 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,113,654 | 1,910,219 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $7,916,746 | 1,903,065 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $8,836,139 | 1,618,341 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $14,896,800 | 1,489,680 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $2,992,276 | 733,402 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,294,762 | 592,963 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $3,515,341 | 589,823 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,588,370 | 485,741 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,770,205 | 448,154 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,172,310 | 695,385 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,960,753 | 927,023 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $14,751,474 | 1,785,893 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $11,312,426 | 730,777 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,233,993 | 898,490 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,893,993 | 859,308 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $27,295,452 | 815,520 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||